Abviris Deutschland GmbH
PrivateLast Round
Series A
Mar 16, 2021
Total Funding Raised
$3.22M
Company Overview
Abviris Deutschland GmbH operates in Healthcare & Life Sciences and is based in Reinfeld. Its latest recorded funding round was a Series A round in March 2021.
Abviris Deutschland GmbH is a biotechnology company that develops and markets immune-oncology diagnostic tests for the early detection of HPV-induced cancers.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Abviris Deutschland GmbH Comparables
Compare Abviris Deutschland GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CURO Biosciences Private Limited | 73% | |
| Vigilant Biosciences | 73% | |
| Epitype GmbH | 67% |
For institutional investors. Book with your work email.
Abviris Deutschland GmbH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 16, 2021 | ||||
| Seed | Jan 21, 2016 |
For institutional investors. Book with your work email.
Abviris Deutschland GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MBG Schleswig-Holstein | Seed, Series A |
| High-Tech Gründerfonds | Seed, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 16, 2021
$2.1M round with High-Tech Gründerfonds and MBG Schleswig-Holstein.
- Jan 21, 2016
$1.09M round led by High-Tech Gründerfonds and MBG Schleswig-Holstein.
For institutional investors. Book with your work email.
Abviris Deutschland GmbH Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Abviris Deutschland GmbH's valuation, stock price, and market status.
Is Abviris Deutschland GmbH a public or private company?
Abviris Deutschland GmbH is a private company.
What is the current stock price of Abviris Deutschland GmbH?
Abviris Deutschland GmbH is a private company, so its shares have no public market price. Caplight tracks Abviris Deutschland GmbH's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Abviris Deutschland GmbH worth (valuation)?
Valuation information for Abviris Deutschland GmbH is not publicly available.
Can I buy Abviris Deutschland GmbH stock?
Abviris Deutschland GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Abviris Deutschland GmbH's last funding round?
Abviris Deutschland GmbH's most recent funding round was Series A on March 16, 2021.
Who are the main investors in Abviris Deutschland GmbH?
Key investors in Abviris Deutschland GmbH include MBG Schleswig-Holstein, High-Tech Gründerfonds.
Will Abviris Deutschland GmbH IPO soon?
No public IPO plans have been announced for Abviris Deutschland GmbH.
How can I track Abviris Deutschland GmbH secondary market activity?
Caplight tracks bids, offers, and trades in Abviris Deutschland GmbH's shares on secondary markets.